PDB Entry - 5VP1
(Status - Released)Summary information:
Title: Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders
PDB DOI: https://doi.org/10.2210/pdb5vp1/pdb
Primary publication DOI: https://doi.org/10.1248/cpb.c17-00564
Entry authors: Hoffman, I.D.
Initial deposition on: 3 May 2017
Initial release on: 27 December 2017
Latest revision on: 13 March 2024
Downloads:
Structure coordinates (PDBx/mmCIF)
Structure coordinates (PDBML)
Structure coordinates (PDB)
X-ray diffraction data (PDBx/mmCIF)
Validation report (mmCIF)
Validation report (PDF)
Validation report (XML)
Links to more resources for 5VP1 at: